Immune activation promotes evolutionary conservation of T-cell epitopes in HIV-1.

by Rafael Sanjuán, Miguel R Nebot, Joan B Peris, José Alcamí
Published 2013-01-01

Converging roads: the latest science from the 2017 IAS HIV Cure and Cancer Forum

by Genevieve E. Martin, José Alcami, Jean-Phillipe Spano, Anna Laura Ross
Published 2017-10-01

Heterogeneity in glycan composition on the surface of HIV-1 envelope determines virus sensitivity to lectins.

by Muzafar Jan, Chitra Upadhyay, José Alcami Pertejo, Catarina E Hioe, Sunil K Arora
Published 2018-01-01

Impact of Transcriptome and Gut Microbiome on the Response of HIV-1 Infected Individuals to a Dendritic Cell-Based HIV Therapeutic Vaccine

by Roque Pastor-Ibáñez, Francisco Díez-Fuertes, Sonsoles Sánchez-Palomino, Jose Alcamí, Montserrat Plana, David Torrents, Lorna Leal, Felipe García
Published 2021-06-01

The CCR5-antagonist Maraviroc reverses HIV-1 latency in vitro alone or in combination with the PKC-agonist Bryostatin-1

by María Rosa López-Huertas, Laura Jiménez-Tormo, Nadia Madrid-Elena, Carolina Gutiérrez, Sara Rodríguez-Mora, Mayte Coiras, José Alcamí, Santiago Moreno
Published 2017-05-01

IL-7 Induces SAMHD1 Phosphorylation in CD4+ T Lymphocytes, Improving Early Steps of HIV-1 Life Cycle

by Mayte Coiras, Mercedes Bermejo, Benjamin Descours, Elena Mateos, Javier García-Pérez, María-Rosa López-Huertas, Michael M. Lederman, Monsef Benkirane, José Alcamí
Published 2016-03-01

Insight in miRNome of Long-Term Non-Progressors and Elite Controllers Exposes Potential RNAi Role in Restraining HIV-1 Infection

by Rubén Ayala-Suárez, Francisco Díez-Fuertes, Esther Calonge, Humberto Erick De La Torre Tarazona, María Gracia-Ruíz de Alda, Laura Capa, José Alcamí
Published 2020-07-01

Functional Consequences for Apoptosis by Transcription Elongation Regulator 1 (TCERG1)-Mediated Bcl-x and Fas/CD95 Alternative Splicing.

by Marta Montes, Mayte Coiras, Soraya Becerra, Cristina Moreno-Castro, Elena Mateos, Jara Majuelos, F Javier Oliver, Cristina Hernández-Munain, José Alcamí, Carlos Suñé
Published 2015-01-01

Nucleic acid recognition and antiviral activity of 1,4-substituted terphenyl compounds mimicking all faces of the HIV-1 Rev protein positively-charged α-helix

by Cristina Medina-Trillo, Daniel M. Sedgwick, Lidia Herrera, Manuela Beltrán, Ángela Moreno, Pablo Barrio, Luis. M. Bedoya, José Alcamí, Santos Fustero, José Gallego
Published 2020-04-01

Promiscuous, Multi-Target Lupane-Type Triterpenoids Inhibits Wild Type and Drug Resistant HIV-1 Replication Through the Interference With Several Targets

by Luis M. Bedoya, Luis M. Bedoya, Manuela Beltrán, Javier García-Pérez, Patricia Obregón-Calderón, Oliver Callies, Ignacio A. Jímenez, Isabel L. Bazzocchi, José Alcamí
Published 2018-04-01

3-Phenylcoumarins as Inhibitors of HIV-1 Replication

by José Alcamí, Mahabir P. Gupta, Eduardo Muñoz, Esther del Olmo, José L. López-Pérez, Luis M. Bedoya, Rocío Sancho, Dionisio Olmedo, Arturo San Feliciano
Published 2012-08-01

Characterization of broadly neutralizing antibody responses to HIV-1 in a cohort of long term non-progressors.

by Nuria González, Krisha McKee, Rebecca M Lynch, Ivelin S Georgiev, Laura Jimenez, Eulalia Grau, Eloísa Yuste, Peter D Kwong, John R Mascola, José Alcamí
Published 2018-01-01

Evolution of Serum Acute-Phase Glycoproteins Assessed by 1H-NMR in HIV Elite Controllers

by Ana-Irene Malo, Joaquim Peraire, Joaquim Peraire, Joaquim Peraire, Joaquim Peraire, Ezequiel Ruiz-Mateos, Jenifer Masip, Jenifer Masip, Jenifer Masip, Núria Amigó, Núria Amigó, Núria Amigó, José Alcamí, José Alcamí, José Alcamí, Santiago Moreno, Santiago Moreno, Josefa Girona, Josefa Girona, Josefa Girona, Graciano García-Pardo, Graciano García-Pardo, Graciano García-Pardo, Rosaura Reig, Francesc Vidal, Francesc Vidal, Francesc Vidal, Francesc Vidal, Antoni Castro, Antoni Castro, Antoni Castro, Lluís Masana, Lluís Masana, Lluís Masana, Lluís Masana, Anna Rull, Anna Rull, Anna Rull, Anna Rull
Published 2021-09-01

14 Treatment with tyrosine kinase inhibitors make PBMCs from patients with chronic myeloid leukemia less susceptible to HIV-1 infection: control of CD4+ T cell activation to contro...

by Mercedes Bermejo, Juan Ambrosioni, Guiomar Bautista, Núria Climent, Elena Mateos, Cristina Rovira, Rafael Duarte, Francisco Cervantes, Montserrat Plana, José M. Miró, José Alcamí, Mayte Coiras
Published 2017-07-01

Neoflavonoids as Inhibitors of HIV-1 Replication by Targeting the Tat and NF-κB Pathways

by Dionisio A. Olmedo, José Luis López-Pérez, Esther del Olmo, Luis M. Bedoya, Rocío Sancho, José Alcamí, Eduardo Muñoz, Arturo San Feliciano, Mahabir P. Gupta
Published 2017-02-01

Generation and characterization of a defective HIV-1 Virus as an immunogen for a therapeutic vaccine.

by Carmen Álvarez-Fernández, Alberto Crespo Guardo, Javier García-Pérez, Felipe García, Julia Blanco, Laura Escribà-García, Jose Maria Gatell, Jose Alcamí, Montserrat Plana, Sonsoles Sánchez-Palomino
Published 2012-01-01

Transcriptome Sequencing of Peripheral Blood Mononuclear Cells from Elite Controller-Long Term Non Progressors

by Francisco Díez-Fuertes, Humberto Erick De La Torre-Tarazona, Esther Calonge, Maria Pernas, María del Mar Alonso-Socas, Laura Capa, Javier García-Pérez, Anavaj Sakuntabhai, José Alcamí
Published 2019-10-01

Association of Transcriptomic Signatures of Inflammatory Response with Viral Control after Dendritic Cell-Based Therapeutic Vaccination in HIV-1 Infected Individuals

by Csaba Fehér, Roque Pastor-lbáñez, Lorna Leal, Montserrat Plana, Mireia Arnedo, Henk-Jan van den Ham, Arno C. Andeweg, Rob A. Gruters, Francisco Díez-Fuertes, José Alcamí, Patrick Aloy, Felipe García
Published 2021-07-01

Use of RT-defective HIV virions: new tool to evaluate specific response in chronic asymptomatic HIV-infected individuals.

by Alberto Crespo Guardo, Carmen Alvarez-Fernández, Hodei Arberas, Javier García-Pérez, Felipe García, Manuel Enric Bargalló, María José Maleno, José María Gatell, Beatriz Mothe, José Alcami, Sonsoles Sánchez-Palomino, Montserrat Plana
Published 2013-01-01

CD4 T cells from patients with chronic myeloid leukemia are resistant to HIV-1 proviral integration and transcription after prolonged withdrawal of treatment with tyrosine kinase i...

by Lorena Vigón, Sara Rodríguez-Mora, Elena Mateos, Valentín García, Juan Ambrosioni, Nuria Climent, Guiomar Bautista, José Alcamí, Juan Luis Steegmann, Montserrat Plana, José M. Miró, Vicente Planelles, María Rosa López Huertas, Mayte Coiras
Published 2019-12-01